MEGAN MADORE: Open Payments
NPI 1891269403 · FLINT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 21 payments from 5 companies in 2025. Trend: 2023 $22 · 2024 $450 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $187 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $137 |
| Forte Bio-Pharma LLC | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $92 |
Products named: Wegovy, REZDIFFRA, Kerendia, PROLATE, JOURNAVX.
Industry payments across TX — which companies pay providers there.
